Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 7/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.48 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.33 |
| ▸ | SHBG | P04278 | 4/20 | 0.33 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GUSB | P08236 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1892098 | 1.00 | ALDH1A1 (0.53) | ALDH1A1MAPTALOX15MEN1KMT2A | |
| SCHEMBL5572206 | 1.00 | ALDH1A1 (0.53) | ALDH1A1MAPTALOX15MEN1KMT2A | |
| SCHEMBL22262018 | 1.00 | ALDH1A1 (0.53) | ALDH1A1MAPTALOX15MEN1KMT2A | |
| SCHEMBL1894115 | 0.80 | ALDH1A1 (0.43) | ALDH1A1MAPTALOX15MEN1KMT2A | |
| SCHEMBL1890530 | 0.80 | ALDH1A1 (0.43) | ALDH1A1MAPTALOX15MEN1KMT2A | |
| SCHEMBL1892388 | 0.80 | ALDH1A1 (0.43) | ALDH1A1MAPTALOX15MEN1KMT2A | |
| SCHEMBL11063624 | 0.80 | ALDH1A1 (0.36) | ALDH1A1MAPTALOX15MEN1KMT2A | |
| SCHEMBL1899126 | 0.80 | ALDH1A1 (0.43) | ALDH1A1MAPTALOX15MEN1KMT2A | |
| SCHEMBL4282246 | 0.80 | ALDH1A1 (0.34) | ALDH1A1MAPTALOX15MEN1KMT2A | |
| SCHEMBL1891855 | 0.80 | ALDH1A1 (0.34) | ALDH1A1MAPTALOX15MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113473974-A | Pharmaceutical composition | 深圳市药欣生物科技有限公司 | 2021-10-01 | — | — | CN | claimed |
| US-20220193095-A9 | PHARMACEUTICAL COMPOSITIONS | Shenzhen Pharmacin Co., Ltd. (CN) | 2022-06-23 | — | — | US | disclosed |
| CN-113473974-A | Pharmaceutical composition | 深圳市药欣生物科技有限公司 | 2021-10-01 | — | — | CN | disclosed |
| US-20200237784-A1 | PHARMACEUTICAL COMPOSITIONS | SHENZHEN PHARMACIN CO LTD (CN) | 2020-07-30 | — | — | US | disclosed |
| US-20140200201-A1 | Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2014-07-17 | — | — | US | disclosed |
| US-20120258938-A1 | Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof | SLOMINSKI ANDREJ (US) | 2012-10-11 | — | — | US | disclosed |
| US-20110118228-A1 | Enzymatic production or chemical synthesis and uses for 5,7-dienes and UVB conversion products thereof | SLOMINSKI ANDRZEJ | 2011-05-19 | — | — | US | disclosed |
| EP-1789384-B1 | EPIMERISATION OF ALLYLIC ALCOHOLS | LEO PHARMA AS (DK) | 2008-10-15 | — | — | EP | disclosed |
| US-20070255066-A1 | Epimerisation of Allylic Alcohols | LEO PHARMA A/S (DK) | 2007-11-01 | — | — | US | disclosed |
| US-20070135395-A1 | Novel method for the preparation of intermediates useful for the synthesis fo vitamin d analogues | LEO PHARMA A/S (DK) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070255066-A1 | Epimerisation of Allylic Alcohols | CYP24A1, CYP2R1, VDR | ALDH1A1 88/4885MAPT 4615/4885ALOX15 176/4885 |
| US-20220193095-A9 | PHARMACEUTICAL COMPOSITIONS | LIPA, LIPC, MGLL | ALDH1A1 852/4885MAPT 2086/4885ALOX15 8/4885 |
| US-20070135395-A1 | Novel method for the preparation of intermediates useful for the synthesis fo vitamin d analogues | CYP2R1, CYP24A1, CYP27B1 | ALDH1A1 910/4885MAPT 4720/4885ALOX15 588/4885 |
| US-20200237784-A1 | PHARMACEUTICAL COMPOSITIONS | LIPA, LIPC, MGLL | ALDH1A1 852/4885MAPT 2086/4885ALOX15 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.